Aasim Sehbai MD in Anniston, Alabama

Home Alabama Anniston

Aasim Sehbai MD has Medical Oncology as his primary medical specialty. Their primary office is: 171 Town Ctr Dr in Anniston, Alabama.

They're a part of the: Alabama Cancer Care, Llc medical group which has around 16 members. You can call their office at 256-847-3369 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1997 (around 27 years of experience). They are listed as doing telehealth appointments.

Aasim S Sehbai MD Office Phone and Directions

Aasim Sehbai MD
Alabama Cancer Care, Llc
171 Town Ctr Dr
Anniston, Alabama 36205
256-847-3369

Patient Ratings
Please rate your experience with Aasim Sehbai MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 256-847-3369

Enter a starting address:

Healthcare Info for Aasim Sehbai MD

Additional Medical Specialties Include:
HEMATOLOGY

Medical School: Sorry, his university is not listed
Graduation Year: 1997
The Primary Medical Specialty for Aasim Sehbai MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 27
PAC (PECOS ID)#: 0042223422
NPI #: 1689629602
NPI Created On: 05/24/2006
NPI Last Updated Listed as: 11/20/2018
Primary Taxonomy Code: 207RH0003X
License Number:
C1-0008513
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Hydration infusion into a vein 31 minutes to 1 hour
Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of drug or substance into a vein for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Application of on-body injector for injection under skin
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
Infusion of different chemotherapy drug or substance into a vein
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
New patient office or other outpatient visit, typically 45 minutes

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788563695

Being Disputed:: No

Product Related: No

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788563697

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788563699

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788563703

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788563701

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788563705

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788563707

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $0

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788563709

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788563711

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $0

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788563713

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Providers in Alabama Cancer Care, Llc

1.Nino Aleksidze

300 Saint Lukes Dr
Montgomery Al 36117-7102
Alabama Cancer Care, Llc
Hematology/oncology

2.Shawnta Anakwah

355 S 2nd St
Gadsden Al 35901-5202
Alabama Cancer Care, Llc
Hematology/oncology

3.Shawnta Anakwah

1608 Glenn Blvd Sw
Fort Payne Al 35968-3522
Alabama Cancer Care, Llc
Hematology/oncology

4.Emma Arquitola

355 S 2nd St
Gadsden Al 35901-5202
Alabama Cancer Care, Llc
Nurse Practitioner

5.Astrid Belalcazar Portacio

291 James Payton Blvd
Sylacauga Al 35150-8047
Alabama Cancer Care, Llc
Hematology/oncology

6.Astrid Belalcazar Portacio

300 Saint Lukes Dr
Montgomery Al 36117-7102
Alabama Cancer Care, Llc
Hematology/oncology

View all 16 members of Alabama Cancer Care, Llc medical group